Michael Pishvaian, MD, PhD
Disclosures: Consulting Fee-AstraZeneca-Principal_Investigator Other_Role-Consulting and one protocol|Consulting Fee-Perthera-Other_Role-Consultant; Stock|Consulting Fee-Merck and Company, Inc.-Other_Role-Consultant|Consulting Fee-Halozyme-Other_Role-Consultant|Consulting Fee-Foundation Medicine-Other_Role-Advisory Board|Grant to institution-Bavarian Nordic-Principal_Investigator-Funding to the institution for a trial|Consulting Fee-Halozyme-Principal_Investigator-Consultant
No Bio Available.